NUZ neurizon therapeutics limited

FDA Application for Orphan Drug Designation , PAA, MPL, page-7

  1. 3,126 Posts.
    lightbulb Created with Sketch. 1191
    My timeline and corporate form are:
    • Q4, 2023: Funds received from the new oppies so remain compliant liquidity wise
    • Q1, 2024 final MND report report released
    • Q1, 2024 PAA receives100% cash takeover offer for all SOI
    • Heads of Agreement entered into which includes an exclusivity period, non refundable upfront payment and inclusion of all options.
    • Takeover recommended by the BoD
    • SHs agree to to takeover


    The big question would be the initial offer price. My guess ~45 cents (subsequently negotiated upwards?????)

    Some wayward thoughts only
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.0¢
Change
0.005(3.23%)
Mkt cap ! $78.76M
Open High Low Value Volume
15.5¢ 16.0¢ 15.5¢ $56.89K 366.1K

Buyers (Bids)

No. Vol. Price($)
2 34020 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 35019 1
View Market Depth
Last trade - 15.56pm 18/07/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.